Third Zurich Immuno-Oncology Symposium
The number of malignancies where immunotherapy has gained approval has rapidly grown and increasingly immunotherapy is being combined with other treatment modalities. Expectations for further progress in the treatment of cancer are high in view of the rapid advancement of science and development of new immunotherapeutic agents. While many physicians have gained experience with the use of immune checkpoint inhibitors, the need for a multidisciplinary network of experts as back up to advise on the diagnosis and treatment of immune-related side effects has become apparent. At the Comprehensive Cancer Center Zürich, such a network has been established.
We invite you to take part in the Third Zürich Immuno-Oncology Symposium organized by the Comprehensive Cancer Center Zürich where a panel of renowned national and international experts will provide you with an overview of the field.